Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients

In this study, we examined the efficacy and toxicity of S-1 with cisplatin as a second-line palliative chemotherapy for gemcitabine-refractory pancreatic cancer patients. Patients who had been previously treated with gemcitabine-based chemotherapy as palliative first-line chemotherapy received S-1/c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: KIM, HYUN JUNG, YUN, JINA, KIM, HAN JO, KIM, KYOUNG HA, KIM, SE HYUNG, LEE, TAE HOON, LEE, SANG-CHEOL, BAE, SANG BYUNG, KIM, CHAN KYU, LEE, NAM SU, MOON, JONG HO, PARK, SANG HEUM, LEE, KYU TAEK, PARK, SEONG KYU, WON, JONG-HO, PARK, HEE SOOK, HONG, DAE SIK
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2012
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3392570/
https://ncbi.nlm.nih.gov/pubmed/22783441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.637
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak